ArticlePLoS neglected tropical diseases2016
Transforming Clinical Data into Actionable Prognosis Models: Machine-Learning Framework and Field-Deployable App to Predict Outcome of Ebola Patients.
Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Significance of Artificial Intelligence in the Study of Virus-Host Cell Interactions.Biomolecules · 2024Review
- An innovative ensemble model based on deep learning for predicting COVID-19 infection.Scientific reports · 2023Article
- Applying Machine Learning to Healthcare Operations Management: CNN-Based Model for Malaria Diagnosis.Healthcare (Basel, Switzerland) · 2023Article
- Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic.Healthcare (Basel, Switzerland) · 2023Review
- Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2023Article
- Implementing predictive tools in surgery: A narrative review in the context of orthopaedic surgery.ANZ journal of surgery · 2022Review
- Constructing, validating, and updating machine learning models to predict survival in children with Ebola Virus Disease.PLoS neglected tropical diseases · 2022Article
- Article
- Predicting special care during the COVID-19 pandemic: a machine learning approach.Health information science and systems · 2021Article
- Machine learning and applications in microbiology.FEMS microbiology reviews · 2021Review
- How artificial intelligence may help the Covid-19 pandemic: Pitfalls and lessons for the future.Reviews in medical virology · 2021Review
- Scope and challenges of machine learning-based diagnosis and prognosis in clinical dentistry: A literature review.Journal of clinical and translational research · 2021Review
- Artificial intelligence as a fundamental tool in management of infectious diseases and its current implementation in COVID-19 pandemic.Environmental science and pollution research international · 2021Review
- Identifying Coronary Artery Lesions by Feature Analysis of Radial Pulse Wave: A Case-Control Study.BioMed research international · 2021Article
- The Promise of AI in Detection, Diagnosis, and Epidemiology for Combating COVID-19: Beyond the Hype.Frontiers in artificial intelligence · 2021Review
- Utility of Artificial Intelligence Amidst the COVID 19 Pandemic: A Review.Journal of medical systems · 2020Review
- How machine learning could be used in clinical practice during an epidemic.Critical care (London, England) · 2020Article
- Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?IEEE open journal of engineering in medicine and biology · 2020Article
- CIRD-F: Spread and Influence of COVID-19 in China.Journal of Shanghai Jiaotong University (science) · 2020Article
- Applications of machine learning techniques to predict filariasis using socio-economic factors.Epidemiology and infection · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAssessment of the response to the 2014-15 Ebola outbreak indicates the need for innovations in data collection, sharing, and use to improve case detection and treatment. Here we introduce a Machine Learning pipeline for Ebola Virus Disease (EVD) prognosis prediction, which packages the best models into a mobile app to be available in clinical care settings. The pipeline was trained on a public EVD clinical dataset, from 106 patients in Sierra Leone. METHODS/PRINCIPAL
findingsWe used a new tool for exploratory analysis, Mirador, to identify the most informative clinical factors that correlate with EVD outcome. The small sample size and high prevalence of missing records were significant challenges. We applied multiple imputation and bootstrap sampling to address missing data and quantify overfitting. We trained several predictors over all combinations of covariates, which resulted in an ensemble of predictors, with and without viral load information, with an area under the receiver operator characteristic curve of 0.8 or more, after correcting for optimistic bias. We ranked the predictors by their F1-score, and those above a set threshold were compiled into a mobile app, Ebola CARE (Computational Assignment of Risk Estimates). CONCLUSIONS/SIGNIFICANCE: This method demonstrates how to address small sample sizes and missing data, while creating predictive models that can be readily deployed to assist treatment in future outbreaks of EVD and other infectious diseases. By generating an ensemble of predictors instead of relying on a single model, we are able to handle situations where patient data is partially available. The prognosis app can be updated as new data become available, and we made all the computational protocols fully documented and open-sourced to encourage timely data sharing, independent validation, and development of better prediction models in outbreak response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.